发明名称 Sulfonyl derivatives
摘要 Described is a sulfonyl derivative represented by the following formula (I): [wherein R<1 >represents a hydrogen atom, a hydroxyl group, a nitro group or the like, R<2 >and R<3 >each independently represents a hydrogen atom, a halogen atom or the like, R<4 >and R<5 >each independently represents a hydrogen atom, a halogen atom or the like, Q<1 >represents a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like, Q<2 >represents a single bond, an oxygen atom or the like, Q<3 >represents any one of the following groups: T<1 >represents a carbonyl group or the like, and X<1 >and X<2 >each independently represents a methine group or a nitrogen atom]; or salt thereof; or solvate thereof. The sulfonyl derivative, salt or solvate according to the present invention is novel as an excellent anticoagulant and it has strong FXa inhibitory action, rapidly exhibits sufficient and long-lasting anti-thrombus effects after oral administration and has less side effects.
申请公布号 US2003232808(A1) 申请公布日期 2003.12.18
申请号 US20020323978 申请日期 2002.12.20
申请人 DAIICHI PHARMACEUTICAL CO., LTD. 发明人 KOBAYASHI SYOZO;KOMORIYA SATOSHI;ITO MASAYUKI;NAGATA TSUTOMU;MOCHIZUKI AKIYOSHI;HAGINOYA NORIYASU;NAGAHARA TAKAYASU;HORINO HARUHIKO
分类号 C07D207/08;C07D207/12;C07D207/22;C07D207/38;C07D211/34;C07D211/70;C07D213/26;C07D213/73;C07D213/74;C07D213/82;C07D213/89;C07D215/48;C07D217/02;C07D233/54;C07D233/64;C07D235/06;C07D239/42;C07D239/48;C07D277/40;C07D295/26;C07D307/84;C07D333/68;C07D401/10;C07D401/12;C07D405/04;C07D409/04;C07D495/04;C07D513/04;(IPC1-7):A61K31/551;A61K31/501;A61K31/502;C0743/02 主分类号 C07D207/08
代理机构 代理人
主权项
地址